Uploaded byPM Society
Building a health intelligence platform to support Joint Working - Hassan Chaudhury
This document discusses building a health intelligence platform to support joint working between the NHS and industry organizations. It provides an example of a joint working case study to track outcomes for patients with diabetes across primary and secondary care. The benefits of the tool include facilitating positive action for at-risk patients and tracking outcomes through a unique dataset that can be analyzed by therapy area. Lessons on good joint working emphasize clear benefits for all sides, engagement during development, and potential for long-term partnerships.
More Related Content
Similar to Building a health intelligence platform to support Joint Working - Hassan Chaudhury
Building a health intelligence platform to support Joint Working - Hassan Chaudhury
- 1. Building a health intelligenceplatform to support Joint Working Hassan Chaudhury, Director of Health Intelligence | Health iQ
- 3. Introduction to Health iQ Jointworking case study Lessons learnt Agenda
- 4. Real World Data ProvenNHS Insight Digital Tools & Solutions
- 5. Joint Working ABPI states:“Joint Working describes situations where, for the benefit of patients, NHS and industry organisations pool skills, experience and/or resources for the joint development and implementation of
- 6.
- 9. Facilitates positive actionfor at-risk patients Track outcomes through unique dataset Platform for multiple therapy areas Benefits of the Tool
- 10. Facilitates positive action Commissioners want best outcomes Agendas:QIPP and medicines optimisation IT obstacles to accessing the relevant data This solution
- 11. Track outcomesUnique dataset Track patientsthrough primary and secondary care Split by therapy and demographics Competitive advantage
- 12. Joint Working Case Study Outcomesin diabetes can already be measured using routinely collected data. However, to break outcomes down by therapy, we need to capture a new dataset. This joint working project will give us unprecedented insight into outcomes in diabetes as we will have access to data that spans primary and secondary care. We will be able to Cohort 1 £400k £450k £512k Cohort 2 £360kk £406k £440k Outcomes in Diabetes Secure patient consent Identify and track cohorts by therapy Determine outcomes and cost them Publish and
- 13. Not designed withsales in mind Damages company brand ‘White elephant’ Bad Joint Working
- 14. Clear, quantified benefitsto all sides All stakeholders engaged in development process Foundation for long-term partnership Good Joint Working
- 15.